Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The association between fibrotic diseases and treatment-resistant hypertension in England.

European journal of preventive cardiology·2025
Same author

A machine learning framework for short-term prediction of chronic obstructive pulmonary disease exacerbations using personal air quality monitors and lifestyle data.

Scientific reports·2025
Same author

Global health impacts of ambient fine particulate pollution associated with climate variability.

Environment international·2024
Same author

Classifying the unclassifiable-a Delphi study to reach consensus on the fibrotic nature of diseases.

QJM : monthly journal of the Association of Physicians·2023
Same author

Defective monocyte-derived macrophage phagocytosis is associated with exacerbation frequency in COPD.

Respiratory research·2021
Same author

Inadequate specialist care referrals for high-risk asthma patients in the UK: an adult population-based cohort 2006-2017.

The Journal of asthma : official journal of the Association for the Care of Asthma·2019
Same journal

Beyond the 5th percentile: rethinking diagnostic thresholds in pulmonary function testing.

The European respiratory journal·2026
Same journal

A Transcriptomic Atlas of Chronic Lung Allograft Dysfunction.

The European respiratory journal·2026
Same journal

Risk of cancer and mortality in patients with interstitial lung diseases: Danish cohort study.

The European respiratory journal·2026
Same journal

Proposing a minimal important difference in NTproBNP in pulmonary arterial hypertension.

The European respiratory journal·2026
Same journal

Unlocking growth potential: Ivacaftor therapy and developmental gains in lung and height in a cohort study of children and young adults with cystic fibrosis.

The European respiratory journal·2026
Same journal

Decoding the Lymphangioleiomyomatosis (LAM) Niche Microenvironment <i>via</i> Integrative Analysis of Single Cell Multiomics and Spatial Transcriptomics.

The European respiratory journal·2026
See all related articles

Related Experiment Video

Updated: Jul 6, 2026

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
04:03

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians

Published on: September 27, 2024

Relationship between depression and exacerbations in COPD.

J K Quint1, R Baghai-Ravary, G C Donaldson

  • 1Academic Unit of Respiratory Medicine, University College London, Hampstead Campus, Rowland Hill Street, London NW3 2PF, UK.

The European Respiratory Journal
|March 7, 2008
PubMed
Summary
This summary is machine-generated.

Frequent exacerbations in chronic obstructive pulmonary disease (COPD) are linked to higher depression scores. Depression worsens quality of life and increases during exacerbations, impacting COPD management.

Related Experiment Videos

Last Updated: Jul 6, 2026

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
04:03

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians

Published on: September 27, 2024

Area of Science:

  • Pulmonary Medicine
  • Psychiatry
  • Epidemiology

Background:

  • Chronic obstructive pulmonary disease (COPD) exacerbations significantly impact patient quality of life and disease progression.
  • Frequent exacerbators experience worse outcomes compared to infrequent exacerbators.
  • The relationship between depression and exacerbation frequency in COPD requires further investigation.

Purpose of the Study:

  • To investigate the association between depression and exacerbation frequency in a well-characterized COPD cohort.
  • To examine the link between depression, systemic inflammation, and social factors in COPD patients.
  • To assess changes in depressive symptoms from baseline to exacerbation periods.

Main Methods:

  • Prospective study utilizing the Centre for Epidemiologic Studies Depression Scale (CES-D) to assess depression.
  • Comparison of baseline depression scores between frequent and infrequent COPD exacerbators.
  • Evaluation of quality of life using the St George's Respiratory Questionnaire (SGRQ).

Main Results:

  • Frequent COPD exacerbators exhibited significantly higher median baseline depression scores than infrequent exacerbators.
  • Depressed COPD patients reported reduced time spent outdoors and significantly worse quality of life (SGRQ scores).
  • Depressive symptoms significantly increased from baseline to exacerbation periods in COPD patients.

Conclusions:

  • This study provides the first evidence of a relationship between depression and exacerbation frequency in COPD.
  • Higher depression levels are associated with more frequent exacerbations and poorer quality of life in COPD.
  • Addressing depression may be a crucial factor in managing COPD exacerbation frequency and improving patient outcomes.